4.Regulatory Affair

4.1.Regulatory Affair

Today’s Iran economics require you to navigate new terrain. Regulatory and commercial endpoints are converging. Market planning can’t wait until FDO (food and drug organization) submission. You need an integrated blueprint to align your commercial goals. Market Access, one of the many Consulting services available from Day Holding, stands ready to help you navigate the value substantiation process, from developing and demonstrating your product’s value platform to winning a preferred market position.
Entering new markets? Day Holding can help you understand all your stakeholders to support payer formulary adoption, negotiation, and messaging. The earlier we start, the better.
We offer comprehensive expertise across the product continuum:
Strategy – To differentiate your product, you must know what payers, providers and patients want and what evidence will demonstrate the value they look for.
Evidence – Beyond clinical trials, you need to provide real-world outcomes to win market adoption. Moving with agility is key to streamline post-approval studies.
Relationships – It’s critical to reach the right payers and decision makers with the right value proposition at the national levels. Market access is about packaging data in the right way, for the right customer at the right time”